HighTower Advisors’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
HighTower Advisors's ONCY Position: Q3 2026 in Review
HighTower Advisors opened a new position in Oncolytics Biotech (ONCY) in Q3 2026: 10,031 shares worth $6.7K. The stake represents ﹤0.01% of the portfolio and ranks #3811 among its holdings.
64 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.
- HighTower Advisors held 10,031 shares of Oncolytics Biotech worth $6.7K as of Q3 2026.
- Oncolytics Biotech was a new HighTower Advisors position in Q3 2026.
- Oncolytics Biotech made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3811 holding.
- 64 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.